153 related articles for article (PubMed ID: 37729596)
21. Hyperdiploidy defines a distinct cytogenetic entity of meningiomas.
Ketter R; Kim YJ; Storck S; Rahnenführer J; Romeike BF; Steudel WI; Zang KD; Henn W
J Neurooncol; 2007 Jun; 83(2):213-21. PubMed ID: 17225936
[TBL] [Abstract][Full Text] [Related]
22. JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia.
Takahashi Y; Ishida H; Imamura T; Tamefusa K; Suenobu S; Usami I; Yumura-Yagi K; Hasegawa D; Nishimura S; Suzuki N; Hashii Y; Deguchi T; Moriya-Saito A; Kosaka Y; Kato K; Kobayashi R; Kawasaki H; Hori H; Sato A; Kudo T; Nakahata T; Oda M; Hara J; Horibe K
Int J Hematol; 2022 Jun; 115(6):890-897. PubMed ID: 35258855
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric DNA index, G-band karyotyping, and comparative genomic hybridization in detection of high hyperdiploidy in childhood acute lymphoblastic leukemia.
Nygaard U; Larsen J; Kristensen TD; Wesenberg F; Jonsson OG; Carlsen NT; Forestier E; Kirchhoff M; Larsen JK; Schmiegelow K; Christensen IJ
J Pediatr Hematol Oncol; 2006 Mar; 28(3):134-40. PubMed ID: 16679935
[TBL] [Abstract][Full Text] [Related]
24. Conserved hierarchical gain of chromosome 4 is an independent prognostic factor in high hyperdiploid pediatric acute lymphoblastic leukemia.
Vojcek Á; Pajor G; Alpár D; Mátics R; Pótó L; Szuhai K; Pajor L
Leuk Res; 2017 Jan; 52():28-33. PubMed ID: 27870946
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response.
Lee SHR; Yang W; Gocho Y; John A; Rowland L; Smart B; Williams H; Maxwell D; Hunt J; Yang W; Crews KR; Roberts KG; Jeha S; Cheng C; Karol SE; Relling MV; Rosner GL; Inaba H; Mullighan CG; Pui CH; Evans WE; Yang JJ
Nat Med; 2023 Jan; 29(1):170-179. PubMed ID: 36604538
[TBL] [Abstract][Full Text] [Related]
26. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
27. Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH).
Ritterbach J; Hiddemann W; Beck JD; Schrappe M; Janka-Schaub G; Ludwig WD; Harbott J; Lampert F
Leukemia; 1998 Mar; 12(3):427-33. PubMed ID: 9529139
[TBL] [Abstract][Full Text] [Related]
28. Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
Li XY; Li JQ; Luo XQ; Wu XD; Sun X; Xu HG; Li CG; Liu RY; Sun XF; Chen HQ; Lin YD; Li CK; Fang JP
BMC Cancer; 2021 Jan; 21(1):59. PubMed ID: 33435902
[TBL] [Abstract][Full Text] [Related]
29. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
30. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Français de Cytogénétique Hématologique.
Blood; 1996 Apr; 87(8):3135-42. PubMed ID: 8605327
[TBL] [Abstract][Full Text] [Related]
31. Hyperdiploidy arising from near-haploidy in childhood acute lymphoblastic leukemia.
Onodera N; McCabe NR; Nachman JB; Johnson FL; Le Beau MM; Rowley JD; Rubin CM
Genes Chromosomes Cancer; 1992 Jun; 4(4):331-6. PubMed ID: 1377941
[TBL] [Abstract][Full Text] [Related]
32. Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method.
Sidana S; Jevremovic D; Ketterling RP; Tandon N; Dispenzieri A; Gertz MA; Greipp PT; Baughn LB; Buadi FK; Lacy MQ; Morice W; Hanson C; Timm M; Dingli D; Hayman SR; Gonsalves WI; Kapoor P; Kyle RA; Leung N; Go RS; Lust JA; Rajkumar SV; Kumar SK
Am J Hematol; 2019 Apr; 94(4):424-430. PubMed ID: 30592078
[TBL] [Abstract][Full Text] [Related]
33. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
[TBL] [Abstract][Full Text] [Related]
34. Probes for hidden hyperdiploidy in acute lymphoblastic leukaemia.
Moorman AV; Clark R; Farrell DM; Hawkins JM; Martineau M; Secker-Walker LM
Genes Chromosomes Cancer; 1996 May; 16(1):40-5. PubMed ID: 9162196
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic significance of chromosome analysis in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group (CCLSG)].
Hyakuna N; Kaneko Y; Katano N; Iwai T; Nagata T; Sakashita K; Takeda O; Tanaka A; Azuma H; Sekine I; Fujimoto T
Rinsho Ketsueki; 2000 Jul; 41(7):576-84. PubMed ID: 11020981
[TBL] [Abstract][Full Text] [Related]
36. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
38. [Report of Chinese Children's Cancer Group acute lymphoblastic leukemia 2015 multicenter study].
Chinese Children′s Cancer Group Acute Lymphoblastic Leukemia 2015 Study Group
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1002-1010. PubMed ID: 36207846
[No Abstract] [Full Text] [Related]
39. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
40. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.
Buitenkamp TD; Izraeli S; Zimmermann M; Forestier E; Heerema NA; van den Heuvel-Eibrink MM; Pieters R; Korbijn CM; Silverman LB; Schmiegelow K; Liang DC; Horibe K; Arico M; Biondi A; Basso G; Rabin KR; Schrappe M; Cario G; Mann G; Morak M; Panzer-Grümayer R; Mondelaers V; Lammens T; Cavé H; Stark B; Ganmore I; Moorman AV; Vora A; Hunger SP; Pui CH; Mullighan CG; Manabe A; Escherich G; Kowalczyk JR; Whitlock JA; Zwaan CM
Blood; 2014 Jan; 123(1):70-7. PubMed ID: 24222333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
